DIA454.99-2.06 -0.45%
SPX6,481.50-20.58 -0.32%
IXIC21,700.39-7.31 -0.03%

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga·08/26/2025 12:09:56
Listen to the news

Gainers

  • Invivyd (NASDAQ:IVVD) stock increased by 132.3% to $1.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $67.2 million.
  • Profusa (NASDAQ:PFSA) stock increased by 49.62% to $0.73. The company's market cap stands at $16.0 million.
  • Allarity Therapeutics (NASDAQ:ALLR) shares rose 38.12% to $1.3. The market value of their outstanding shares is at $13.7 million.
  • Firefly Neuroscience (NASDAQ:AIFF) shares rose 27.36% to $3.3. The company's market cap stands at $34.6 million.
  • Serina Therapeutics (AMEX:SER) stock increased by 26.41% to $7.13. The company's market cap stands at $57.8 million.
  • Leap Therapeutics (NASDAQ:LPTX) shares moved upwards by 25.8% to $0.39. The market value of their outstanding shares is at $12.8 million.

Losers

  • ESSA Pharma (NASDAQ:EPIX) stock fell 66.3% to $0.26 during Tuesday's pre-market session. The market value of their outstanding shares is at $37.0 million.
  • Femasys (NASDAQ:FEMY) shares fell 38.15% to $0.32. The company's market cap stands at $16.7 million.
  • OSR Holdings (NASDAQ:OSRH) stock decreased by 18.96% to $0.82. The market value of their outstanding shares is at $21.8 million.
  • Molecular Partners (NASDAQ:MOLN) stock declined by 13.41% to $3.65. The market value of their outstanding shares is at $155.4 million. The company's, Q2 earnings came out yesterday.
  • HCW Biologics (NASDAQ:HCWB) shares fell 11.72% to $4.9. The company's market cap stands at $11.9 million.
  • Nanobiotix (NASDAQ:NBTX) stock fell 11.38% to $8.73. The market value of their outstanding shares is at $472.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.